| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| Automated CPR Devices Market Size 2024 |
USD 140.26 Million |
| Automated CPR Devices Market, CAGR |
5.05% |
| Automated CPR Devices Market Size 2032 |
USD 208.02 Million |
Market Overview
The Automated CPR Devices market is projected to grow from USD 140.26 million in 2024 to USD 208.02 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.05%.
The Automated CPR Devices market is driven by the rising incidence of cardiac arrest, increasing awareness about emergency medical services, and the growing adoption of advanced medical technologies. The demand for automated CPR devices is further propelled by their ability to provide consistent and effective chest compressions, improving patient survival rates. Key trends include technological advancements in device portability and efficiency, integration with real-time monitoring systems, and expanding applications in both pre-hospital and in-hospital settings. Additionally, supportive government initiatives and funding for emergency medical services bolster market growth, ensuring broader accessibility and adoption of these life-saving devices.
The Automated CPR Devices market exhibits significant regional diversity, with North America, Europe, and Asia-Pacific being the primary markets. North America leads due to advanced healthcare infrastructure and high adoption rates of new technologies. Europe follows, driven by stringent healthcare regulations and increasing awareness of emergency medical services. Asia-Pacific is rapidly growing, fueled by expanding healthcare investments and rising prevalence of cardiovascular diseases. Key players driving the market include Schiller AG, Michigan Instruments, Defibtech LLC, ZOLL Medical Corporation, Corpuls, SunLife Science, Ambulanc (Shenzhen) Tech. Co. Ltd. (Amoul), Shenzhen Bangvo Technology Co., Ltd., and Stryker Corporation, contributing to innovation and market expansion globally.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Drivers
Increasing Prevalence of Cardiovascular Diseases (CVDs)
The rising incidence of heart attacks, strokes, and other cardiac emergencies is a primary driver for the adoption of automated CPR devices. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. In the United States, one person dies every 33 seconds from cardiovascular disease. These devices offer a crucial intervention in the critical minutes following cardiac arrest, significantly improving survival rates. As cardiovascular diseases continue to be a leading cause of mortality worldwide, the demand for reliable and efficient emergency response tools, such as automated CPR devices, becomes more pronounced. These devices ensure consistent and effective chest compressions, providing vital support in the initial moments of a cardiac event.
Growing Awareness About CPR Importance
Increased public awareness campaigns highlighting the significance of early CPR in improving survival rates are driving demand for automated CPR devices. For instance, June 1-7 each year is National CPR and AED Awareness Week, spotlighting how lives can be saved if more Americans know CPR and how to use an AED. Organizations and governments are actively promoting CPR training and the availability of automated CPR devices in public spaces. This heightened awareness is leading to a wider acceptance of these devices as essential life-saving equipment. The public’s growing understanding of the importance of immediate intervention during cardiac emergencies underscores the need for accessible and user-friendly CPR devices, contributing to market growth.
Technological Advancements and Integration with Other Medical Devices
Continuous advancements in CPR technology are resulting in more efficient and effective devices. For instance, drones are being tested to deliver AEDs that can be used to help quickly revive people who’ve had an out-of-hospital cardiac arrest. Features such as improved compression depth, rate, and recoil are enhancing the performance of these devices, making them more reliable in emergency situations. Additionally, the integration of automated CPR devices with other life-saving equipment, such as defibrillators, is creating new market opportunities. This combination enhances the overall effectiveness of emergency response, providing comprehensive support during cardiac events. The seamless integration of these technologies ensures that patients receive the highest standard of care, driving further adoption and innovation in the market.
Rising Demand for Out-of-Hospital Care and Government Initiatives
The focus on providing immediate care in pre-hospital settings has increased the need for portable and user-friendly automated CPR devices. These devices can be deployed by laypersons until professional medical help arrives, bridging the gap in emergency care. Government support and regulations mandating the availability of automated CPR devices in public places are also driving market growth. These initiatives aim to improve cardiac arrest survival rates by ensuring that life-saving equipment is readily available. Furthermore, the aging population, which is more susceptible to cardiovascular diseases, is contributing to higher demand for these devices, as they provide critical support during cardiac emergencies among older individuals.
Market Trends
Technological Advancements and Integration
The automated CPR devices market is witnessing significant technological advancements, particularly in the integration of these devices with defibrillators. For instance, a study published in the National Library of Medicine demonstrated the development of an automated CPR (A-CPR) apparatus that combines an automatic chest compression device (ACCD) with an automated external defibrillator (AED). This integration resulted in significant hemodynamic outcomes and provided continuous chest compressions during defibrillation, shortening the time required for defibrillation and improving treatment outcomes. Additionally, continuous improvements in the devices’ compression depth and rate are making them more effective in mimicking human CPR. For example, the American Heart Association reports that high-quality CPR should aim for a compression depth of at least 2 inches (5 cm) and a rate of 100-120 compressions per minute. Modern automated CPR devices are designed to consistently meet these standards, ensuring optimal CPR delivery.
Expanding Adoption in Public Places and User-Friendliness
There is a growing emphasis on the widespread adoption of automated CPR devices in public places, driven by government mandates and organizational policies aimed at improving survival rates from cardiac arrest. Airports, schools, shopping malls, and other high-traffic areas are increasingly being equipped with these life-saving devices. This trend underscores the recognition of the critical role that immediate CPR can play in saving lives. To support this widespread adoption, manufacturers are focusing on user-friendly designs and intuitive interfaces, making these devices accessible to a broader audience, including laypersons. Clear instructions, visual aids, and minimal training requirements are becoming essential features, ensuring that individuals without medical backgrounds can confidently use the devices in emergencies. Additionally, the integration of data analytics capabilities is emerging as a valuable trend. These analytics enable healthcare providers to track device usage, performance, and patient outcomes, offering insights that can inform improvements in device design and emergency response protocols. This data-driven approach enhances the overall effectiveness of automated CPR devices and supports continuous innovation in the market.
Market Challenges Analysis
High Cost and Limited Reimbursement
The adoption of automated CPR devices faces significant challenges primarily due to their high initial investment costs. For instance, some automated CPR devices can cost between USD 15,000 and USD 20,000, while others are available for a price tag of around $9,191.76 per set. Hospitals, emergency medical services, and public places must allocate substantial funds to acquire these life-saving technologies. This financial burden is particularly challenging in resource-constrained settings, where budget limitations can severely restrict access to advanced medical devices. Moreover, the lack of adequate reimbursement policies within many healthcare systems exacerbates this issue. Without financial incentives or coverage for the costs associated with automated CPR devices, hospitals and emergency services may be discouraged from investing in these technologies. This financial uncertainty creates a significant barrier to widespread adoption, limiting the potential benefits these devices could offer in improving cardiac arrest survival rates.
User Acceptance, Training, and Regulatory Hurdles
Ensuring the proper usage of automated CPR devices necessitates comprehensive training for both healthcare professionals and laypersons. Overcoming resistance to new technology and implementing effective training programs can be challenging. Many users may be hesitant to adopt new devices due to unfamiliarity or concerns about reliability. Effective training programs are essential to ensure that users can confidently operate the devices in emergency situations, but organizing and maintaining these programs require time, effort, and resources. Additionally, regulatory hurdles present another substantial challenge. Obtaining necessary approvals from regulatory bodies can be a time-consuming and costly process. Automated CPR devices must comply with stringent safety and efficacy standards, and meeting these requirements can delay market entry. The regulatory landscape can be complex and varies by region, adding to the challenges manufacturers face in bringing their products to market swiftly.
Market Segmentation Analysis:
By Product:
The automated CPR devices market is segmented by product into piston-based devices and load-distributing band-based devices. Piston-based devices are widely recognized for their precise control over compression depth and rate, making them highly effective in delivering consistent CPR. These devices are commonly used in hospital settings and by emergency medical services due to their reliability and ease of use. Load-distributing band-based devices, on the other hand, utilize a broad band to compress the chest, distributing the force more evenly and reducing the risk of injury. These devices are particularly beneficial in pre-hospital settings and during patient transport, where stability and ease of application are crucial. Both product types play a vital role in improving the outcomes of cardiac arrest by ensuring high-quality chest compressions, thereby driving market growth.
By Modality:
In terms of modality, the market is categorized into battery-driven and electrically-driven automated CPR devices. Battery-driven devices offer the advantage of portability, making them ideal for use in various emergency scenarios, including ambulances and remote locations. Their lightweight and compact design allow for easy transportation and quick deployment, ensuring timely intervention during cardiac emergencies. Electrically-driven devices, while typically larger, provide continuous power supply and are commonly used in hospital settings where access to electrical outlets is readily available. These devices are preferred in intensive care units (ICUs) and emergency departments for their robust performance and reliability. The choice between battery-driven and electrically-driven devices depends largely on the intended application and setting, with both modalities contributing significantly to the overall growth and versatility of the automated CPR devices market.
Segments:
Based on Product:
- Piston-based Devices
- Load-distributing Band-based Devices
Based on Modality:
- Battery-driven
- Electrically-driven
Based on End-user:
- Hospitals (Emergency Departments, ICUs, and Others)
- Ambulatory Medical Centers
- Specialty Clinics
- Emergency Medical Services (Ambulances and Air Ambulances)
- Independent Catheterization Labs
- Long-term Care Centers
Based on the Geography:
- North America
- Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Regional Analysis
Europe
Europe follows closely, accounting for approximately 35% of the global automated CPR devices market share. Countries like Germany, the United Kingdom, and France are major contributors, driven by their advanced emergency medical services and high healthcare expenditure. For instance, in the UK, there are over 30,500 out-of-hospital cardiac arrests (OHCAs) per year in non-clinical settings. The average survival rate after out-of-hospital cardiac arrest (OHCA) in the UK was 8-9% in 2019. The European market is characterized by a strong focus on evidence-based medicine, with numerous clinical trials and studies supporting the efficacy of automated CPR devices. There’s an increasing trend towards the integration of these devices with other emergency medical equipment, creating comprehensive resuscitation systems. The region’s stringent regulatory framework ensures high-quality standards for automated CPR devices, fostering trust among healthcare providers and patients. Europe also leads in the development of smart, data-driven CPR devices that can provide real-time feedback and performance metrics to improve resuscitation outcomes. The market sees significant demand from both urban and rural emergency services, as automated CPR devices help address the challenges of providing consistent, high-quality chest compressions during patient transport over long distances. As awareness of the importance of high-quality CPR continues to grow, coupled with ongoing improvements in emergency medical services across the continent, the European market for automated CPR devices is poised for sustained growth.
North America
North America dominates the global automated CPR devices market, holding approximately 45% of the market share. This significant presence is primarily attributed to the region’s advanced healthcare infrastructure, high adoption rates of medical technologies, and stringent emergency medical service (EMS) protocols. The United States leads the market, driven by a well-established network of emergency responders and hospitals that prioritize the integration of automated CPR devices into their resuscitation protocols. The region’s market is characterized by a strong emphasis on research and development, with continuous innovations in device design and functionality to improve CPR efficacy and patient outcomes. There’s a growing trend towards the adoption of lightweight, portable automated CPR devices that can be easily deployed in various emergency scenarios, including out-of-hospital cardiac arrests. Additionally, the increasing prevalence of cardiovascular diseases and the aging population in North America contribute to the sustained demand for these devices. The market also benefits from favorable reimbursement policies and substantial investments in healthcare technology, further solidifying its leadership position in the global automated CPR devices market.
Key Player Analysis
- Schiller AG
- Michigan Instruments
- Defibtech LLC
- ZOLL Medical Corporation
- Corpuls
- SunLife Science
- Ambulanc (Shenzhen) Tech. Co. Ltd. (Amoul)
- Shenzhen Bangvo Technology Co., Ltd.
- Stryker Corporation
- Others
Competitive Analysis
The Automated CPR Devices market is highly competitive, with leading players such as Stryker Corporation, ZOLL Medical Corporation, Corpuls, and Schiller AG at the forefront. These companies dominate the market through extensive research and development, innovative product offerings, and strategic partnerships. Stryker Corporation leverages its vast distribution network and advanced manufacturing technologies to maintain a competitive edge. ZOLL Medical Corporation focuses on integrating their devices with advanced defibrillation technology, enhancing overall emergency response efficiency. Corpuls and Schiller AG excel in providing robust, user-friendly devices that are highly effective in both hospital and pre-hospital settings. Additionally, emerging players like Shenzhen Bangvo Technology Co., Ltd. and Defibtech LLC are enhancing market dynamics with their innovative, cost-effective solutions. The intense competition among these key players fosters continuous innovation, ensuring the market remains dynamic and responsive to the evolving needs of emergency medical services globally.
Recent Developments
- In January 2024, SunLife Science reported a successful case where their Auto CPR device saved a 50-year-old man’s life during a cardiac arrest incident in Suzhou.
- In March 21, 2024, Stryker launched two new products at the Criticare National Conference in Kolkata, India.
- In July 2023, ZOLL Medical Corporation introduced a new automated CPR device system called ‘AutoPulse’. This innovative system is designed to assist emergency medical services (EMS) personnel in providing high-quality chest compressions in challenging environments, such as cramped spaces and steep stairwells.
- In June 2023, Nordic Capital acquired a majority share in Corpuls, a medical technology company specializing in emergency medical solutions and cardiac resuscitation. This acquisition aims to support Corpuls’ next phase of growth, with a focus on expanding its telemedicine offerings and accelerating growth in the hospital segment.
- In April 2023, the European Resuscitation Council (ERC) partnered with Sunlife Science, a leading China-based provider of CPR solutions, with the aim to improve the survival rate and outcomes of cardiac arrest patients.
Market Concentration & Characteristics
The Automated CPR Devices market exhibits moderate to high market concentration, dominated by a few key players such as Stryker Corporation, ZOLL Medical Corporation, Corpuls, and Schiller AG. These companies maintain significant market shares through continuous innovation, extensive research and development, and strategic collaborations. The market is characterized by rapid technological advancements, with a strong focus on improving device efficacy, portability, and user-friendliness. Additionally, regulatory compliance and the integration of advanced features like real-time data analytics are critical factors influencing product development. The presence of emerging players and increasing investments in healthcare infrastructure, particularly in developing regions, are driving competitive dynamics. This concentration and focus on innovation ensure that the market remains dynamic and capable of meeting the evolving needs of emergency medical services globally.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Report Coverage
The research report offers an in-depth analysis based on Product, Modality, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
- The demand for automated CPR devices will continue to rise due to increasing awareness of cardiac arrest intervention.
- Technological advancements will lead to more efficient and user-friendly automated CPR devices.
- The integration of automated CPR devices with other emergency medical equipment will enhance overall emergency response effectiveness.
- Emerging markets will see significant growth in adoption driven by improved healthcare infrastructure and rising prevalence of cardiovascular diseases.
- Government regulations mandating the availability of CPR devices in public spaces will drive market growth.
- Continuous research and development will result in new product innovations and improved device performance.
- The healthcare sector will expand its use of automated CPR devices due to their proven efficacy in improving patient outcomes.
- Increased focus on training and education will enhance user confidence and device effectiveness.
- The development of portable and compact devices will expand their use in out-of-hospital settings.
- Strategic partnerships and collaborations among key players will drive market expansion and innovation.
